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INTRODUCTION 
A central problem in developmental neurobiology is understanding the 
cellular and molecular mechanisms that generate the diversity of cell types 
found in the nervous system. Although the general problem of cell type 
specification can be addressed in many non-neuronal tissues, it is par­
ticularly challenging in the nervous system, because of the enormous 
variety of cell types that exist, and the phenotypic plasticity they display. In 
recent years, several technical breakthroughs have permitted an intensive 
analysis of cell lineage relationships in various parts of the vertebrate 
nervous system. These have included the development of recombinant 
retroviruses for genetic marking of cell fate (Sanes et al 1986; Turner 
& Cepko 1987) and membrane-impermanent lineage tracers for micro­
injection of single progenitor cells (Holt et al 1988; Wetts & Fraser 1988). 
These techniques have revealed that in many (but not all) systems, indi­
vidual neural precursor cells give rise to a variety of different cell types, 
thus demonstrating that they are multipotent. In the case of the neural 
crest, application of both techniques has indicated that many neural crest 
cells are multipotent, before (Bronner-Fraser & Fraser 19&8, 19&9; Frank 
129 
o 147-006X/93/030 1-0129$02.00 
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
93
.1
6:
12
9-
15
8.
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
by
 A
cq
ui
sit
io
ns
 L
ib
ra
ria
n 
on
 0
4/
14
/1
5.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
130 ANDERSON 
& Sanes 1991) or shortly after (Fraser & Bronner-Fraser 1991) they migrate 
from the neural tube. 
If neural precursors are multipotent, how do they choose their fates? In 
principle, fates could be determined stochastically, be governed by cell­
autonomous developmental programs, or be controlled by environmental 
signals. In the case of the neural crest, transplantation of cell populations 
has indicated that the fate(s) of these populations can be altered by chang­
ing their environment (for reviews, see Le Douarin 1980, 1982). However, 
there have been relatively few cases in which it has been possible to identify 
the specific signals that control neural cell fate and study their actions on 
identified cells. In the optic nerve, studies of a bipotential glial progenitor 
cell, the 02A cell, have suggested that one fate, the oligodendrocyte, is the 
"default" pathway for the cell, whereas the other fate, the type 2 astrocyte, 
is dependent upon instructive signals (which include CNTF and extra­
cellular matrix-associated factors) (for reviews, see Lillien & Raft' 1990; 
Raff 1989). Although this system has proven excellent for analysis at the 
cellular level, it has been less accessible for study at the molecular 
levcl. 
One neural crest lineage that has been investigated in detail is the 
sympathoadrenal (SA) lineage (Landis & Patterson 1981). This lineage 
derives from neural crest cells that migrate ventrally from the apex of the 
neural tube to the dorsal aorta, where they aggregate and differentiate to 
form sympathetic neurons, or to the adrenal gland primordia, where they 
differentiate to form chromaffin cells (Figure 1). Chromaffin cells are 
round secretory cells that lack the axons and dendrites characteristic of 
sympathetic neurons; their secretory vesicles are also larger than those of 
neurons (Doupe et al 1985a). A third and minor SA cell type, the small 
intensely fluorescent (SIF) cell, has an intermediate morphology with short 
proccsses (Eranko 1975). A striking feature of these cell types is that they 
can be phenotypically interconverted by specific environmental signals 
(Patterson 1978). This plasticity has been interpreted to reflect develop­
mental history, i.e. sympathetic neurons, adrenal chromaffin cells, and SIF 
cells can be interconverted because they may develop from a common 
embryonic progenitor cell (Anderson & Axel 1986; Doupe et al 1985b; 
Unsicker et al 1989). Moreover, the ability of glucocorticoids (GC) and 
nerve growth factor (NGF) to interconvert or maintain these phenotypes 
has suggested that these factors may be important environmental deter­
minants of cell fate in vivo (Aloe & Levi-Montalcini 1979; Anderson 1988; 
Doupe et aI1985a,b; Seidl & Unsicker 1989a,b; Unsicker et al 1978). 
Recently, it has become possible to isolate SA progenitors from rat 
embryos by using monoclonal antibodies, and derive immortal cell lines 
from these progenitors (Anderson 1988; Birren & Anderson 1990; 
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NOTOCHORD 
a If SYMPATHETIC GANGLION RESTRICTION T<>---- � .. 
� .-., SASUBLlNEA�ft.. 
n �ADRENAL � )J GLAND 
DORSAL 
AORTA 
Figure 1 Schematic cross-section through a midgestational rat embryo at the caudal thoracic 
level, showing migratory route taken by neural crest cells that give rise to the sympatho­
adrenal lineage. For clarity, other crest derivatives, such as sensory neurons, melanocytes, 
and glia, are omitted. Cells at several different stages of development are shown in the 
same figure. 
Carnahan & Patterson 199Ib). These advances have permitted a critical 
test of the "common progenitor" hypothesis and an examination of the 
influences of environmental signals on this embryonic cell. This review 
summarizes new insights into the biology of the SA lineage gained over 
the last several years as a consequence of these studies. A minireview on 
this Lopic has recently appeared elsewhere (Patterson 1990). 
HISTORICAL OVERVIEW: PLASTICITY AND 
DEVELOPMENTAL HISTORY 
Experimental evidence for a close developmental relationship between 
chromaffin cells and sympathetic neurons initially came from the obser­
vation that transplantation of postnatal adrenal medullary tissue into the 
anterior chamber of the eye produced outgrowth of neuritic processes 
(Olson 1970). Un sicker et al ( 1978) subsequently demonstrated that neurite 
outgrowth could be induced from dissociated postnatal chromaffin cells 
by NGF in vitro. This induction of neurite outgrowth could be blocked 
or delayed by GC, which suggests that the (presumably) high local con­
centration of steroids produced by the adrenal cortex (Roos 1967) is 
important for maintaining the endocrine phenotype of the medullary cells. 
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132 ANDERSON 
Nerve growth factor also promoted neurite outgrowth from a clonal cell 
line, PC 12, derived from a rat adrenal medullary tumor (Greene & Tischler 
1976). Moreover, injections ofNGF into rat fetuses caused the replacement 
of chromaffin cells by ganglionic neurons in situ (Aloe & Levi-Montalcini 
1979). Taken together, these data revealed that the chromaffin phenotype 
is plastic and identified NGF and GC as environmental signals of potential 
importance in controlling the fate of these cells in vivo. 
Although these early in vitro studies documented short-term neurite 
outgrowth from chromaffin cells in response to NGF, they did not deter­
mine whether these endocrine cells could undergo a complete phenotypic 
conversion into bona fide sympathetic neurons. This was resolved by 
Doupe et al ( 1985a), who demonstrated that individual chromaffin cells 
could convert into cells that are morphologically and antigenically indis­
tinguishable from true sympathetic neurons, when exposed to NGF for 
several weeks. Furthermore, such a transdifferentiation occurred in single 
cells, in the absence of DNA synthesis or cell division (Doupe et al 1985b) 
[however, in the absence of mitotic inhibitors, NGF exerted a mitogenic 
effect on chromaffin cells (Lillien & Claude 1985)]. The conversion to a 
neuronal phenotype also involved the de novo induction of expression of 
neuron-specific genes (Anderson & Axel 1985). In these studies, GC not 
only inhibited neuronal transdifferentiation, but also acted as a survival 
factor for the chromaffin cells (Doupe et al 1985a). 
Based on these and the preceding observations, it was hypothesized 
that chromaffin cells and sympathetic neurons derive from a common 
embryonic progenitor (Doupe et al 1985b; Landis & Patterson 1981). A 
cell with the properties expected of such a progenitor was identified in 
cultures of neonatal sympathetic ganglia (Doupe et al 1985b) (although 
the lack of markers for this cell made it difficult to establish its relationship 
to embryonic precursor cells in vivo). This cell could differentiate into a 
SIF-like phenotype in moderate concentrations of GC ( 10- 8 M) or to an 
adrenergic chromaffin cell in micromolar Gc. Once generated, such SIF­
like cells could be converted to sympathetic neurons by exposure to NGF 
(Doupe et al 1985b). This observation, coupled with the fact that the 
conversion of chromaffin cells to sympathetic neurons appeared to occur 
through a SIF-like intermediate, led to the proposal that SIF cells represent 
the embryonic progenitor of both adrenal medullary cells and sympathetic 
neurons (Doupe et al 1985b). High GC would favor the differentiation of 
SIF cells into chromaffin cells. Nerve growth factor would promote their 
differentiation into sympathetic neurons. And, a combination of NGF 
and moderate concentrations of GC would maintain or stabilize the SIF 
phenotype. This idea was appealing in that it provided a role for SIF cells 
(Eranko 1975), whose function had previously been controversial. 
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DEVELOPMENT OF THE SYMPATHOADRENAL LINEAGE 133 
Fetal SA Progenitors are Bipotential, but Distinct from SIF 
Cells 
A direct test of the bipotential progenitor hypothesis was made possible by 
the development of immunologic methods to isolate fetal SA progenitors. 
These cells have been isolated from E14.5 rat adrenal glands (Anderson 
1988; Anderson & Axel 1986) by using monoc1onal antibody HNK-l (Abo 
& Balch 198 1), and from sympathetic ganglia (Carnahan & Patterson 
1991b) by using novel monoclonal antibodies generated by an immuno­
suppression technique (Carnahan & Patterson 1991 a). Progenitors from 
fetal adrenal glands have also been isolated by density gradient cen­
trifugation (Seidl & Un sicker 1989a). Quantitative analysis of such purified 
cell populations (Anderson & Axel 1986; Carnahan & Patterson 199Ib), 
as well as serial observations of identified cells (Anderson & Axel 1986; 
Michelsohn & Anderson 1992) has confirmed that many such progenitors 
are bipotential, able to develop into either chromaffin cells or sympathetic 
neurons depending upon the culture conditions. Nevertheless, the SA 
progenitor appears to have lost the ability to give rise to other crest 
derivatives, such as glia (D. L. Stemple and D. J. Anderson 1991, unpub­
lished), and therefore represents a relatively late stage in neural crest 
l ineage d iversification. The idea that the gl ia and sympathoadrenal l ineages 
diverge early in sympathetic gangliogenesis is supported by retroviral 
lineage-tracing experiments in fetal superior cervical ganglion (SCG) (Hall 
& Landis 199I a). 
Fetal SA progenitors can be demonstrated to be bipotential in vitro, 
but do such cells exist in vivo? Individual cells coexpressing neuron-specific 
and chromaffin-specific antigenic markers have been observed in early 
(E 12. 5) sympathetic ganglia primordia (Anderson et al 1991; Carnahan & 
Patterson, 1991a). Subsequently, the chromaffin-specific markers are lost 
by the cells that remain in the ganglia (Anderson et al 1991; Carnahan & 
Patterson 199I a), whereas the neuron-specific markers are lost by pro­
genitors that continue migrating to the adrenal gland (Anderson 1988; 
Anderson & Axel 1986; Vogel & Weston 1990). The observation of such 
transiently dual phenotype cells provides circumstantial evidence for the 
existence of a bipotential SA progenitor in vivo. Is this cell a SIF cell? 
Although the morphology and high catecholamine content of the embry­
onic SA progenitor is similar to that of a postnatal SIF cell, SA progenitors 
and SIF cells are distinct by antigenic criteria (Carnahan & Patterson 
199Ia), and SIF cells develop later, not earlier, than principal neurons in 
sympathetic ganglia (Hall & Landis 1991 b). These data suggest that the 
embryonic SA progenitor is different from a SIF cell. However, SIF cells 
have a similar developmental potential as the SA progenitor (Doupe et al 
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134 ANDERSON 
1985b) and might represent a postnatal/adult form of the SA progenitor 
(Carnahan & Patterson 1991 b), as has been described in the glial 02A 
lineage (Wolswijk & Noble 1989). 
ROLE OF POLYPEPTIDE GROWTH FACTORS IN 
THE NEURONAL DIFFERENTIATION OF SA 
PROGENITOR CELLS 
Fetal SA Progenitors are Initially Responsive to Fibroblast 
Growth Factor (FGF) but not to NGF 
The ability of NGF to trigger neurite outgrowth from postnatal chromaffin 
cells, SIF cells, and PCl 2  cells initially suggested that NGF is an important 
determinant of neuronal fate in the SA lineage. Indeed, neonatal post­
mitotic sympathetic neurons are absolutely dependent upon NGF 
for survival both in vitro (Chun & Patterson 1977; Levi-Montalcini & 
Angeletti 1963) and in vivo (Levi-Montalcini & Booker 1960). But, freshly 
isolated SA progenitors from fetal adrenal glands are initially unresponsive 
to NGF, by criteria of neurite outgrowth, mitotic rate, and survival 
(Anderson & Axel 1986; S. 1. Birren and D. 1. Anderson 1991, unpub­
lished). Similar observations have been made for neuronal precursors from 
chick (Ernsberger et al 1989a) and mouse (Coughlin & Collins 1985) 
sympathetic ganglia. These data raise several new questions: Why are 
SA progenitors unresponsive to NGF? Which factors promote the acqui­
sition of NGF-responsiveness and NGF-dependence? Are there other 
factors that substitute for NGF in the early stages of neuronal differen­
tiation? 
Answers to some of these questions have come, in part, from studies of 
an SA progenitor cell line, called MAR (Myc-infected, Adrenal-derived, 
RNK-l + ) cells. MAR cells were produced by retroviral transduction of 
the avian v-myc oncogene into SA progenitors isolated from fetal adrenal 
glands by fluorescence-activated cell sorting; their morphology and anti­
genic phenotype are similar to those of their primary counterparts (Birren 
& Anderson 1990). Like primary SA progenitors, MAR cells fail to 
respond to NGF by criteria of neurite outgrowth, survival, or induction 
of neuron-specific genes (Birren & Anderson 1990). The large number of 
homogeneous cells provided by the MAR line has permitted a molecular 
analysis of NGF receptor expression in SA progenitors. Northern blot 
analysis has indicated that MAH cells grown in the absence of dexa­
methasone express neither mRNA encoding p75 (Birren & Anderson 
1990), the low affinity NGF receptor (Johnson et al 1986; Radeke et al 
1987), nor p140trk (Birren et al 1992), recently identified as a signal-trans-
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DEVELOPMENT OF THE SYMPATHOADRENAL LINEAGE 135 
ducing component of the NGF receptor (Kaplan et al 1991a; Klein et al 
1991). Thus, the lack of NGF responsiveness appears due, at least in 
part, to a lack of NGF receptor expression. However, it may also reflect 
the absence of some other component(s) of the NGF signal-transduction 
pathway. 
If NGF does not promote the initial neuronal differentiation of SA 
progenitors, do other factors play this role? Experiments in PCI 2  cells have 
identified bFGF (RydeI & Greene 1987; Togari et al 1985), interleukin-6 
(Satoh et al 1988), and "pleiotrophin" (Kuo et al 1990; Li et al 1990) as 
factors able to mimic the ability ofNGF to induce neurite outgrowth and, 
in the case of bFGF, neuron-specific gene expression (Leonard et a1 1987; 
Stein et al 1988). In postnatal adrenal chromaffin cells, both bFGF (Stemple 
et a11988) and aFGF (Claude et a1 1988) promote neuronal differentiation 
and increase cell proliferation. Unlike NGF, however, FGF cannot act as 
a long-term survival factor for sympathetic neurons (Stemple et al 1988). 
Similarly, bFGF can induce proliferation and neurite outgrowth from 
both MAH cells (Birren & Anderson 1990) and primary SA progenitor 
cells (S. J. Birren and D. J. Anderson 1991, unpublished), but does not 
support their long-term survival. Taken together, these results suggest 
that FGF, rather than NGF, may promote the proliferation and initial 
neuronal differentiation of embryonic SA progenitors, whcreas NGF acts 
as a survival factor for mature neurons. In chromaffin cells, FGF can 
induce neuronal differentiation independent of its ability to induce pro­
liferation (Stemple et al 1988); it is not yet clear whether this is also true 
for embryonic SA progenitors. 
Other factors besides bFGF also stimulate the proliferation or survival 
of immature sympathetic neuroblasts, including depolarization, insulin, 
insulin-like growth factor I (IGF-I), and vasoactive intestinal peptide 
(DiCicco-Bloom & Black 1988, 1989; DiCicco-Bloom et al 1990; Pincus 
et al 1 990; Wolinsky et al 1985); for review see Rohrer ( 1990). In such 
studies, it is often difficult to distinguish between the mitogenic effect of a 
growth factor and its ability to enhance simply the survival of proliferating 
cells without affecting their rate of cell division. Two other "growth" 
factors, ciliary neurono-trophic factor (CNTF) and cholinergic differ­
entiation factor/ leukemia inhibitory factor (CDF/ LIF), inhibit the pro­
liferation of sympathetic neuroblasts and MAH cells (Ernsberger et al 
1989; Ip et al 1992). With the exception of NGF (Levi-Montalcini 
& Booker 1960; Rohrer et al 1988), the requirement for any of these 
growth factors in sympathetic neuronal proliferation or differentiation in 
vivo has not yet been assessed. However, embryonic chick sympathetic 
ganglia contain bFGF immunoreactivity at early stages of gangliogenesis 
(Kalcheim & Neufeld 1990). 
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136 ANDERSON 
Induction of NGF Receptors and NGF-Responsiveness in SA 
Progenitors 
The survival of sympathetic and other neurons is independent of NGF 
before their axons reach the sources of NGF in the periphery (Davies et 
al 1987; Korsching & Thoenen 1988). How do differentiating sympathetic 
neurons acquire their responsiveness to, and ultimately their trophic depen­
dence upon, NGF? Because SA progenitors initially do not appear to 
express NGF receptors, a critical early step must be the induction of such 
receptors. Tn MAH cells, treatment with both FGF and NGF (but not 
with either factor alone) leads to a small population of cells (0.5-10%), 
which differentiate to postmitotic neurons. Such cells are NGF-dependent, 
which implies that they express functional NGF receptors (Birren & 
Anderson 1990). This suggested that FGF might induce the expression of 
NGF receptors, and a low-level induction of p75 (LNGFR) mRNA 
was observed in MAH cells exposed to FGF for several days (Birren & 
Anderson 1990). 
Experiments with cloned NGF receptor genes suggest that the expres­
sion of p75 is probably not sufficient for NGF responsiveness [and may 
not be necessary, either (Weskamp & Reichardt 1991)], and that p 140trk is 
required to form functional, high-affinity NGF receptors (Hempstead et 
aI 1991). In MAH cells, p l40trk mRNA is not directly induced by FGF (or 
any other growth or neurotrophic factors tested); however, it is induced by 
membrane depolarization, which also induces a functional NGF-response 
(Birren et al 1992). Depolarization does not induce neurite outgrowth, 
however, which indicates that the induction of trk can be experimentally 
uncoupled from neuronal differentiation. The ability of FGF to induce 
NGF-responsiveness in a small proportion of MAH cells (Birren & Ander­
son 1990) may reflect an indirect induction of trk expression, perhaps via 
synaptic activity. In primary chick sympathetic neurohlasts, depolarization 
augmented cell survival in the presence of NGF (Ernsberger et al 1989a), 
although the mechanism of this effect was not investigated. Taken together, 
however, these results suggest that the electrical excitation of developing 
sympathetic neuroblasts may stimulate their acquisition of trophic-factor 
responsiveness. Such a mechanism could coordinate the formation of 
stable presynaptic and postsynaptic connections by a developing neuron. 
Other mechanisms may also contribute to the acquisition of trophic 
factor responsiveness and dependence in developing neuroblasts. In chro­
maffin cells, FGF can induce an NGF-dependence in transdifferentiating 
neurons that are already NGF-responsive (Stemple ct al 1988). Seemingly 
spontaneous acquisition of trophic factor dependence has been observed 
for primary sensory neurons in vitro (Vogel & Davies 1991); howcver, it 
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DEVELOPMENT OF THE SYMPATHOADRENAL LINEAGE 137 
was not determined whether these cells were already responsive to the 
neurotrophic factor [brain-derived neurotrophic factor (BDNF)] at the 
time of their initial isolation. Retionic acid induces both NGF-dependence 
and the expression of high-affinity NGF receptors in chick sympathetic 
neuroblasts that bear low affinity NGF receptors (Rodriguez-Tebar & 
Rohrer 1991). In the rat SA progenitor, however, retinoic acid does not 
appear to induce NGF responsiveness or expression of p l 40lrk mRNA 
(Birren et al 1992); this difference may reflect either a species difference or 
differences in the relative stages of development examined in the two 
systems. The availability of cloned probes for both p75 and p 140lrk should 
help resolve these issues. 
ROLE OF GC IN CHROMAFFIN CELL 
DIFFERENTIATION 
Positive and Negative Action of GC on the SA Progenitor 
The migration of SA progenitors to the adrenal gland primordium brings 
them to a microenvironment that contains a high concentration of GC 
hormones, synthesized by the adrenal cortex. Earlier studies have estab­
lished two distinct influences of GC on the chromaffin phenotype, one 
positive and one negative. Glucocorticoids act positively to up regulate 
the expression of phenylethanolamine-N-methyl transferase (PNMT), 
the epinephrine-synthesizing enzyme (Bohn et al 198 I; Jiang et al 1989; 
Pohorecky & Wurtman 197 1; Teitelman et al 1982; Wurtman & Axelrod 
1966). This gene is expressed by a majority of adrenal chromaffin cells, 
but not by sympathetic neurons (Bohn et al 1982). Glucocorticoids also 
act negatively to inhibit neuronal differentiation induced by both NGF 
(Unsicker et al 1978) and FGF (Stemple et al 1988). 
The ability of GC to exert both positive and negative effects on the SA 
progenitor reflects the capacity of the GC receptor (GCR) to function as 
both a positive- and negative-acting transcriptional regulatory molecule 
(for review, see Beato 1989). In the case of the SA progenitor, some of the 
targets of these positive and negative actions of the OCR are known. The 
sequence of the PNMT gene contains several consensus glucocorticoid­
response elements (GREs) (Batter et al 1988), and at least one of these is 
functional in cell transfection assays (Ross et al 1990). These data suggest 
that thc PNMT gene is a direct target of positive regulation by OC. 
Glucocorticoids also repress the expression of several neuron-specific 
genes, including pcripherin (Leonard et al 1987), seo 1 0 (Stein et al 1988), 
and OAP-43 (Federoff et al 1988), in PCI2 cells. Negative GREs have not 
yet been identified for these genes in functional assays; therefore, it is not 
clear whether the action of GC on these genes is direct. However, a 
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138 ANDERSON 
promoter fragment from the metalloprotease gene transin (stromelysin) 
contains elements for both positive regulation by NGF, and negative 
regulation by GC, in transfected PCI2 cells (Machida et aI1989). Further 
analysis of this promoter should shed light on the inhibitory actions of 
Gc. 
Glucocorticoids exert both positive and negative influences on embry­
onic SA progenitors, as well as on PCI2 cells, but these influences occur 
on different developmental schedules. Primary E14.5 SA progenitors are 
competent to respond to GC by inhibition of neuronal differentiation 
within the first 15-24 hours of culture, but do not express PNMT (Michel­
sohn & Anderson 1 992). Although GCs are absolutely required for PNMT 
expression (Seidl & Unsicker 1989b), competence to express PNMT does 
not develop until after several days in culture (Michelsohn & Anderson 
1992), which reflects the schedule of PNMT appearance in vivo (Bohn et 
a1 1981; Ehrlich et al 1989; Teitelman et al 1982). In vivo, PNMT expression 
is also preceded by the inhibition of neuronal differentiation, as indicated 
by the extinction of neuron-specific markers (Anderson & Axel 1986; 
Anderson et al 199 1; Anderson & Michelsohn 1989; Vogel & Weston 
1990). 
Both the early and late effects of GC appear mediated by the type II 
GCR (Anderson & Michelsohn 1989; Michelsohn & Anderson 1992). How 
can the same receptor control two different developmental events in the 
same cell at two different times? One clue comes from a pharmacological 
analysis of GC actions. A fivefold higher dose of GC is required for half­
maximal induction ofPNMT, than for half-maximal inhibition of neurite 
outgrowth. This suggests that the induction of PNMT transcription may 
require a higher concentration of ligand-bound GCR than does the 
repression of neuron-specific genes. The idea that different GC-responsive 
genes within the same cell may require different levels of ligand-bound 
receptor is supported by recent studies of model promoters (Diamond et 
al 1990; Simons et al 1989). The timing of PNMT induction might then 
be determined by the accumulation of GCR to a threshold level (Anderson 
& Michelsohn 1989). Consistent with this idea, GCR levels in fetal chro­
maffin cells increase in parallel with PNMT expression (Seidl & Un sicker 
1989b), and PNMT+ chromaffin cells appear to have higher levels of GCR 
immunoreactivity than PNMT- chromaffin cells (Ceccatelli et al 1989). 
SEQUENTIAL STEPS IN CHROMAFFIN DIFFERENTIATION ARE DEPENDENT EVENTS 
Why should chromaffin cell development involve two sequential GC­
dependent steps? If SA progenitors are cultured for two days in the absence 
of GC, many cells extend neurites; these cells subsequently fail to express 
PNMT in response to GC, as if committed to neuronal differentiation 
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DEVELOPMENT OF THE SYMPATHOADRENAL LINEAGE 139 
(Michelsohn & Anderson 1992). If neuronal differentiation is suppressed 
by progesterone during this initial period, then an increased number of 
precursors acquire competence to express PNMT ( Michelsohn & Ander­
son 199 2). Thus, the first step in chromaffin differentiation (the inhibition 
of neuronal commitment) is a prerequisite for the second step (the decision 
to express PNMT). Neuronal commitment correlates with the expression 
of an antigenic marker, B2 in vivo (Anderson & Axel 1986; Anderson et 
a1 199 1) (Figure 2). Consistent with the in vitro data, a lack of B2 expression 
by adrenal medullary cells precedes their expression of PNMT in vivo 
(Anderson et al 1991). Such a two-step mechanism may ensure that epi­
nephrine is synthesized only by those progenitors that have first migrated 
Bipotential 
sympatho;tdrenal progenitor 
FGF 
+ .on / \. glu depOlarizati  ,\COCOrlicOid 
�B2+  
committed neuroblast 
NGF 
SA-1+ 
chromaffin precursor 
gain of 
J 
competence 
glucocorticoid 
PNMT+ 
adrenergic chromaffin cell 
� neuron-specl�ic � gene expression 
� chromaffin-specific 
� aene eXDression 
Figure 2 Progressive stages in the development of the SA lineage. Changes in marker 
expression that correlate with these stages are shown. Cross-hatched lines in bipolential SA 
progenitor indicate that both neuron-specific and chromaffin-specific genes are coexpressed. 
Committed neuroblasts have lost competence to respond to GC by expression of a chromaffin 
phenotype. Acquisition of NGF receptors appears to occur at or after the committed 
neuroblast stage, but also occurs in chromaffin precursors. For further details, see Figure 6 
in Carnahan & Patterson (I99Ib). 
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to the adrenal gland. Not all chromaffin cells express PNMT, however 
(Hillarp & H6kfeit 1953). This may reflect the fact that GC do not induce 
competence per se, but only increase the probability that competence will 
be acquired (Michelsohn & Anderson 1992). 
Taken together, these recent studies indicate that the development of 
both chromaffin cells and sympathetic neurons is progressive and can be 
dissected into a series of steps (Figure 2). In vitro, these steps appear to 
involve changes in the responsiveness of cells to environmental signals: 
Developing sympathetic neurons gain responsiveness to NGF and lose 
sensitivity to GC-inhibition, whereas developing chromaffin cells acquire 
competence to express PNMT. These steps are associated with changes in 
antigenic phenotype (Figure 2), thus allowing them to be identified in vivo 
(Anderson et a1 1991; Carnahan & Patterson 1991a). An analogous series 
of stepwise changes in factor responsiveness, which are correlated with 
changes in cell morphology and antigenic phenotype, has been documented 
for glial progenitors in the 02A lineage (Gard & Pfeiffer 1990). Such 
progressive mechanisms seem likely to be a general feature of vertebrate 
neurogenesis and have been identified genetically in invertebrate nervous 
systems, as well (for reviews, see Ghysen & Dambly-Chaudiere 1989; Jan 
& Jan 1990). 
Regulatory Circuits Controlling the Chromaffin-Neuron 
Decision 
Glucocorticoids inhibit the neuronal differentiation of the SA progenitor 
in two ways: They directly suppress expression of the neuronal phenotype 
and they block the ability of FGF and NGF to promote this phenotype. 
In PCI2 cells, GCs inhibit the ability of FGF and NGF to up-regulate 
ncuron-specific gcnes (Leonard et a11987; Stein et al 1988b). Interestingly, 
this antagonism is a "two-way street": FGF and NGF can inhibit the 
ability of GC to uprcgulate chromaffin-abundant genes, such as TH (Stein 
et al 1988). In other words, at saturating concentrations, FGF /NGF and 
GC reciprocally inhibit each other's actions. What is the molecular basis 
of such reciprocal inhibition? 
Recently, novel mechanisms of transcriptional regulation by steroid 
hormone receptors have been uncovered (for review, see Schule & Evans 
1991). These mechanisms may have relevance for understanding the 
reciprocal antagonism between FGF/NGF and GC in the SA lineage. 
Glucocorticoid receptors interact with members of the AP-l family of 
transcriptional regulatory proteins, such as c-fos and CAjun. In some cases, 
this interaction occurs "off" the DNA (Schule et al 1990; Yang-Yen et al 
1990); in others it occurs "on" the DNA (Diamond et al 1990). In PC12 
cells, both FGF and NGF cause an induction of such AP-I genes as c-jun 
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(for review, see Sheng & G reenberg 1990). Although it is not yet certain 
that AP-l molecules are required for neuronal differentiation in the SA 
lineage, overexpression of c-jun promotes autonomous neuronal differ­
entiation of PC12 cells (I. Verma 1991, personal communication). The 
ability of GCR to inhibit the activity of AP- l  could, therefore, provide a 
molecular mechanism for the antagonism ofFGF/NGF-induced neuronal 
differentiation by corticosteroids. Moreover, because an "off-the-DNA" 
interaction between AP-l and the GCR results in a mutual inhibition of 
DNA-binding activity (Schiile et al 1990; Yang-Yen et al 1990), it could 
explain the reciprocal antagonism observed between FGF/ NGF and GC 
at saturating ligand concentrations (Figure 3). 
Such a mechanism is particularly attractive, because it would generate 
a "titratable" system: Progenitors containing more ligand-bound GCR 
than AP-l would favor chromaffin differentiation, whereas progenitors 
containing more active AP-l than GCR would favor neuronal differ­
entiation. These two situations would obtain when the dominant environ­
mental signals were GC or FGF/ NGF, respectively. In this way, such a 
regulatory circuit (Figure 3) would create a cell whose choice of fate was 
exquisitely sensitive to the relative concentrations of competing signals in 
its local environment-precisely the behavior observed for SA progenitor 
cells. The actual role of GCR-AP-l antagonistic interactions in the SA 
progenitor remains to be investigated. However, thc establishment of thesc 
mechanisms in model systems provides a promising new handle on the 
regulatory circuits that control the chromaffin-neuron decision. 
FGF, NGF GC 
, � 
, � 
, � 
'" � 
0� ; tAP-1 GCR 
� 
+ Q 0l-e: ____ �e: ______ 
__ 
neural-specific gene chromaffin-specific gene 
Figure 3 Hypothetical regulatory interactions between transcription factors in the AP-I 
family and the GC receptor. These interactions occur in model systems, but have not yet 
been documented in the SA lineage. Positive and/or negative effects of AP-I and GCR on 
the transcription of neuron-specific and chromaffin-specific genes are also illustrated. There 
is no evidence for a direct negative effect of AP-I on chromaffin-specific gene expression, 
although this has not been excluded. 
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THE SA PROGENITOR HAS THE POTENTIAL TO 
GENERATE NON-CATECHOLAMINERGIC 
DERIVATIVES 
Coexpression of Multiple Neurotransmitter Enzyme Genes 
in SA Progenitors 
The repertoire of fates available to the SA progenitor is not restricted to 
catecholaminergic cell types. Sympathetic neurons and chromaffin cells 
can convert from a catecholaminergic to a cholinergic neurotransmitter 
phenotype in vitro (Doupe et al 1985b; Ogawa et al 1984; Patterson & 
Chun 1977). Experiments in vivo have shown that such a conversion 
actual1y occurs for the sympathetic neurons that innervate the sweat glands 
(Landis & Keefe 1983; Schotzinger & Landis 1988, 1990). Biochemical 
experiments in vitro have identified CDF jLIF (Yamamori et al 1989) and 
CNTF (Saadat et al 1 989) as two molecules that are sufficient to induce 
the noradrenergic to cholinergic conversion. Whether these molecules are 
actual1y the cholinergic differentiation factors in the sweat gland is now 
under investigation (Rao & Landis 1990). The demonstration of cholin­
ergic potential in sympathetic ne�rons and adrenal chromaffin cells raises 
questions regarding how early in the SA lineage this potential is established, 
and whether SA progenitors have other developmental potentials, as well. 
Recent experiments have shed light on the answers to both of these 
questions. ACh synthesis has been detected in both primary SA progenitors 
and in MAR cells (Vandenbergh et al 1991). In addition, MAR cells 
transcribe low levels of ChAT mRNA. These data suggest that the cholin­
ergic potential is established early in the SA lineage, before the choice 
between chromaffin and neuronal fates. In addition to ChAT mRNA, 
MAR cells contain low levels (approximately one copy per cell) of tryp­
tophan hydroxylase (TpH) mRNA (Vandenbergh et al 199\). TpH tran­
scripts were also detected in tissue from superior cervical ganglia and 
adrenal medulla, which indicates that the expression detected in MAR 
cells is not an artifact of immortalization. By contrast, no transcripts from 
either of the two glutamic acid decarboxylase (GAD) genes, GADI and 
GAD2, were detected in SA lineage cells or tissues (Vandenbergh et al 
1991). These data suggest that SA progenitors may express a restricted 
repertoire of neurotransmitter biosynthetic enzyme genes. 
The detection of TpR transcripts in MAH cells suggests that SA pro­
genitors may have a serotonergic potential, as well as a cholinergic and 
catecholaminergic potential. Consistent with this notion, neonatal sym­
pathetic neurons can synthesize serotonin in response to heart cell con­
ditioned medium (Sah & Matsumoto 1987). Is this serotonergic potential 
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actually utilized in vivo? Serotonin is one of the neurotransmitters thought 
to be used by enteric neurons and their endocrine counterparts, thyroid 
medullary "C" cells, both of which derive from the neural crest (Barasch 
et al 1987). This is consistent with the possibility that the SA progenitor 
may also give rise to enteric neurons (Figure 4), as discussed below. 
SA Progenitors and Enteric Progenitors Are Similar 
Circumstantial evidence supports the hypothesis that progenitors of enteric 
neurons may be similar, if not identical, to SA progenitors. A population 
of cells in the embryonic foregut transiently expresses SA lineage markers, 
including TH (Cochard et al 1978; Teitelman et al 1978), DBH, and high­
affinity catecholamine uptake (Baetge & G ershon 1989; Jonakait et al 
1985). Expression of these markers in the gut appears at El1.5-EI2.5, the 
same time as in sympathetic ganglia. The gut cells also express SA-I 
(Carnahan et al 1991 ) and, subsequently, B2, like neuroblasts in the sym-
o 
uncommitted neural crest cell 
/ jMASH� 
\11 0 -
Sensory 
progenitor SA progenitor Schwann cell progenitor 
-- , 
•.. 
' "
0" 
-------.. - ..... . 
o 0 
�$!ro� -"<"-
chromaffin cell sympathetic 
neurons 
(adrenergic & cholinergic) 
Figure 4 The SA lineage in the context of other neural crest lineages. A progenitor­
progeny relationship between SA precursors and enteric neurons has not yet been formally 
demonstrated. Dotted line indicates that the lineage relationship between SA progenitors and 
thyroid C cells is speCUlative. MASH I is hypothesized to play a role in the restriction of 
multipotent neural crest cells to the SA lineage, but the nature of this role is not established. 
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144 ANDERSON 
pathetic ganglia (Anderson et a1 1991; Carnahan et aI1991). Not only are 
SA lineage markers expressed in gut cells, but conversely serotonin (Soinila 
et al 1989), a marker of enteric neurons, is transiently expressed by SA 
progenitors. Although shared expression of antigenic markers cannot 
rigorously prove a lineage relationship, the fact that so many independent 
gene products are expressed by both cells in the sympathetic ganglia and 
cells in the foregut suggests that these two populations may be closely 
related (Carnahan & Patterson 199Ia). 
The SA progenitor-like cells in the embryonic foregut are likely to bc 
precursors of enteric neurons. This conclusion is based on the fact that 
neuronal "linking markers," such as neurofilament and DBH, are initially 
coexpressed with SA lineage markers in the foregut population and persist 
in enteric neurons after the SA markers have disappeared (Baetge & 
G ersohn 1989 ; Baetge et al 1990 ; Carnahan et al 1991). The persistent 
expression of such linking markers suggests that the transient SA pro­
genitor cell-like population in the gut does not die, but rather extinguishes 
expression of such genes as TH and SA-l and differentiates into enteric 
neurons. This implies that the environment of the gut may influence a 
decision between a sympathoadrenal and an enteric phenotype. Consistent 
with this idea, injections of NGF in vivo prolong TH expression in gut 
neurons (Kessler et al 1979 ). 
The idea that the environment of the gut suppresses the expression of 
SA properties is also supported by in vitro experiments. Precursors of 
enteric neurons from the vagal neural crest express TH if cultured in NGF 
(Mackey et al 1988) and extinguish TH when cocultured with gut tissue 
(Coulter et aI 1988). It is not yet known whether coculture with gut tissue 
can suppress TH expression in sympathetic neuroblasts. Direct tests of 
the postulated lineage relationships between SA progenitors and enteric 
neurons are clearly required before further progress on this problem can 
be made. But the available data, while indirect and circumstantial, suggest 
that the SA progenitor may have a repertoire of several developmental 
fates (Figure 4) (Carnahan et al 1991 ). This repertoire appears to be 
reflected in the transcriptional activation of a battery of genes that sub­
serve several possible classical neurotransmitter phenotypes, including 
catecholaminergic, cholinergic, and serotonergic (Vandenbergh et al 
1991), as well as multiple neuropeptide phenotypes (Nawa & Patterson 
1990). The expression of a particular phenotype from this repertoire is 
then selected according to the various inductive and repressive signals 
encountered by the cell as it migrates to different embryonic environ­
ments (Anderson & Axei.1986). Following their differentiation into post­
mitotic cells, sympathetic neurons can undergo further phenotypic 
diversification with respect to their neurotransmitter and neuropeptide 
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content, in response to target-derived instructive signals (for review, see 
Patterson 1990). 
COMMITMENT OF EARLY NEURAL CREST CELLS 
TO THE SA LINEAGE 
If SA progenitors have a restricted repertoire of developmental fates, how 
does this repertoire become established in neural crest ontogeny? Single 
cell lineage tracing experiments in vivo (Bronner-Fraser & Fraser 1989; 
Frank & Sanes 1991; Fraser & Bonner-Fraser 1991), as well as clonal 
analyses in vitro (Baroffio et al 1988; Dupin et al 1990; Sieber-Blum 
& Cohen 1980) have established that many early neural crest cells are 
muitipotent. An individual cell may give rise to a clone containing not 
only catecholaminergic (SA) derivatives, but also glia, melanocytes, and 
sensory neurons. Because the SA progenitor seems to have lost the capacity 
to generate these latter three cell types, it may have become develop­
mentally restricted. How might such a restriction event occur? 
Experiments in vitro using avian neural crest cells have suggested that 
environmental influences, such as soluble factors (Howard & Bronner­
Fraser 1985), extracellular matrix (Maxwell & Forbes 1990a,b), and the 
timing of cell dispersal (Vogel & Weston 1988) may influence the expression 
of the catecholaminergic phenotype. Ablation and rotation experiments 
in chick embryos have indicated that the notochord/floorplate and the dor­
sal aorta are required for the expression of catecholamines by neural crest 
cells in vivo (Stern et al 1991). The observation that SA progenitors can 
develop in different types of clones, which contain various subsets of other 
crest derivatives, has suggested that commitment may occur by a stepwise 
process involving "oligopotential" (i.e. partially restricted) intermediates 
(Anderson 1989; LeDouarin et al 1991; Sieber-Blum 1990). However, there 
is currently little evidence to distinguish such a progressive model from a 
stochastic one, a problem that has dogged the dissection oflineage commit­
ment in the immune system for many years (Suda et al 1984). The study 
of lineage restriction in the neural crest has been limited by the difficulty of 
obtaining early markers whose expression precedes that of such differentia­
tion products as TH (Barald 1988). Such early markers can be useful in 
identifying influences that might predispose cells to a particular sublineage. 
A Vertebrate Homologue of Drosophila achaete-scute Is an 
Early Marker of SA Lineage Commitment 
One recent approach that has proven productive in identifying such an 
early marker is to isolate vertebrate homologues of Drosophila genes that 
control early stages in neurogenic determination. The achaete-scute complex 
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146 ANDERSON 
of Drosophila contains four genes whose function is required for the develop­
ment of subsets of neuroblasts in appropriate positions in the fly embryo 
(Ghysen & Dambly-Chaudiere 1988). Molecular analysis of this complex 
has revealed that these genes encode nuclear regulatory proteins of the 
basic helix-loop-helix (bHLH) class (Alonso & Cabrera 1988; G onzalez et 
al 1989; Romani et al 1989; Villares & Cabrera 1987). Included in this gen­
eral class are MyoD and related proteins, encoded by mammalian genes that 
play a central role in myogenic determination (for review, see Weintraub et 
al 1991). The isolation of a Drosophila MyoD homologue, nautilus, which 
is specifically expressed in fly myogenic precursors (Michelson et al 1990), 
suggested that there has been a remarkable parallel conservation of amino 
acid seq uenee and tissue-specifici ty for at least some b HLH cell-type determina­
tion genes. Consistent with this idea, a recently isolated Mammalian Achaete­
Scute-Homologous (MASH) gene, MASH I (Johnson et aI1990), is specifically 
expressed by subsets of neural precursors in the rat embryo (Lo et a1 1991). 
A striking feature of MASHI expression in the peripheral nervous 
system is that it is restricted to sympathetic ganglion primordia, but 
appears one day earlier than differentiation genes, such as TH (Lo et 
al 1991). MASHI expression subsequently overlaps that of TH , but is 
eventually extinguished. MASHI is also expressed by scattered cells in 
the foregut, which further supports the idea of a close developmental 
relationship between SA and enteric crest derivatives (see above). MASHI 
is notably absent from dorsal root ganglia, glia, and melanocytes, as well 
as from migrating neural crest cells. It thus appears to mark neural crest 
cells immediately before their restriction to the SA lineage. In the CNS, 
MASHI is expressed by positionally restricted subsets of precursor cells 
in the spinal cord and forebrain (Lo et a1 1991). The fact that MASH I is 
a transcription factor (Johnson et al 1992) and is homologous to a family 
of neural determination genes in Drosophila further suggests that it may 
have a causal role in SA lineage commitment (Figure 4). The isolation 
of vertebrate homologues of other Drosophila genes involved in neural 
determination (for review, see Campos-Ortega & Jan 1991), such as 
daughterless (Murre et alI989a,b), Notch (Coffman et a1 1990; Weinmaster 
et aI 1991), and the RNA-binding protein Elav (Marusich & Weston 1992; 
Szabo et al 1991), suggests that this general approach should be successful 
in identifying molecules that will, at the very least, serve as useful markers 
and may at best provide handles on molecular mechanism. 
Transcription Factors for Genes Expressed in SA 
Progenitors 
Another approach to the molecular biology of SA lin cage commitment is 
to isolate nuclear regulatory factors required for the expression of genes, 
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such as SCGI0, neurofilament, TH, and DBH, which are specifically 
transcribed in SA progenitors. A first step toward this goal is to delineate 
the cis-acting elements with which these factors interact. A 5.8 kb fragment 
of the human dopamine-j3 hydroxydase (DBH) gene has recently been 
shown to direct the expression of j3-galactosidase to developing sym­
pathetic ganglia and adrenal medulla in transgenic mice (Kapur et a1 1 99 1 ;  
Mercer et al 1991). Surprisingly, however, expression i s  also detected 
in cell types that normally express TH, but not DBH. An interesting 
interpretation of this observation is that thc DBH promoter fragment 
contains regulatory elements common to all catecholamine biosynthetic 
enzyme genes, but lacks silencer elements that normally restrict DBH 
expression to noradrenergic cell types (Mercer et al 1 99 1 ). The TH pro­
moter has also been extensively analyzed. Transfection experiments in 
PCI 2  cells have defined an enhancer necessary for cell type-specific 
expression (Gandelman et al 1990; Harrington et al 1987). AlthQugh an 
intact human TH gene is specifically expressed in transgenic mice (Kaneda 
et al 1991), promoter fragments able to direct correct heterologous trans­
gene expression have not yet been identified for this gene. The transcription 
factors that interact with these cis-acting control elements have yet to be 
identified. 
Promoters for several genes expressed not only in the SA progenitor, 
but also in most or all neurons, have also been studied. These include the 
type II sodium channel (Maue et al 1990), SCG I 0 (a growth-associated 
protein) (Mori et a1 1990; Vandenbergh et a1 1 989; Wuenschell et aI 1 990), 
and synapsin I (Sauerwald et al 1990) (for further discussion, see the article 
by Mandel & McKinnon in this volume). A surprising common feature of 
the regulation of these genes is that specificity is determined, at least in 
part, by selective derepression. The genes contain silencer elements that 
repress expression in non-neuronal cells and tissues; repression is specifi­
cally relieved in the nervous system. R ecent data suggest that a common 
silencer mechanism may control the expression of both the type II sodium 
channel (Kraner et al 1992) and SCG 1 0 (Mori et al 1992) genes. It remains 
to be determined when and how derepression occurs during neural crest 
development. 
These data do not preclude a role for specifically expressed positive­
acting factors in neurogenic determination. AP-2, a transcriptional acti­
vator protein, is specifically expressed in early migrating neural crest celIs 
(MitchelI et al 1991). An insulin enhancer-binding homeodomain protein, 
1sl-1, is expressed in precursors to sensory and sympathetic neurons (as 
weIl as in motoneurons) (Thor et· al 1991; T. Jessell 199 1 ,  personal com­
munication). A role for this molecule as a positive-acting transcription 
factor is supported by its sequence similarity with mec-3, a homeodomain 
A
nn
u.
 R
ev
. N
eu
ro
sc
i. 
19
93
.1
6:
12
9-
15
8.
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
by
 A
cq
ui
sit
io
ns
 L
ib
ra
ria
n 
on
 0
4/
14
/1
5.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
1 48 ANDERSON 
protein required for the development of mechanosensory neurons in C. 
elegans (Karlsson et a1 1990; Way & Cha1fie 1988). 
THE SA LINEAGE IN MEDICINE AND DISEASE 
The study of the SA lineage has provided insights not only into vertebrate 
neurogenesis, but also into the diagnosis and treatment of human disease. 
For example, neuroblastomas and pheochromocytomas are tumors of the 
sympathoadrenal lineage that afflict young children (Israel 1991). Analysis 
of the phenotypes of these tumors using antibody and cloned cDNA 
markers (Cooper et al 1990a; Trojanowski et al 199 1) has suggested that 
different subtypes of neuroblastomas may correspond to discrete stages of 
differentiation in the human SA lineage (Cooper et al 1990b; Molenaar et 
al 1990), which have been developmentally arrested by the process of 
oncogenic transformation. In particular, tumors can be defined that have 
either a more chromaffin-like phenotype or a more neuronal phenotype. 
These phenotypes correspond to the SA- l + B2- "chromaffin precursor" 
stage and the SA- l - B2+  "committed neuroblast" stage identified in the 
rat SA lineage (Figure 2) (Anderson et al 199 1 ;  Carnahan & Patterson 
199 1b). Interestingly, there is a correlation between tumor phenotype and 
prognosis. Patients whose tumors show a neuroblast phenotype have a 
much higher probability of spontaneous remission than those with tumors 
of a chromaffin phenotype (Israel 1 99 1 ). The neuroblastic tumors may die 
because they become NGF-dependent and lack access to NGF. If so, a 
potential therapy for the more malignant chromaffin-like tumors might 
involve their in situ conversion to neuroblastic tumors, by using FGF 
and/or GCR antagonists. Other treatments might involve such factors 
as CDF/LIF and CNTF, which show an antiproliferative effect on SA 
progenitors (Ernsberger et al 1989b; Ip et al 1992). 
Another area of medical research bearing on the SA lineage is the 
development of cell-replacement therapies for neurodegenerative diseases 
(Bjorklund 1991; Gage et aI 199l ). Adrenal chromaffin cell autografts have 
been used for the treatment of Parkinson's disease (Allen et al 1989), 
because they secrete dopamine, the missing neurotransmittcr. However, 
such autografts have met with limited success. A more promising approach 
involves fetal donor tissue, which survives much better than adult tissue 
after grafting (Brundin et al 1986). The practical and ethical constraints 
on obtaining fetal donor tissue suggest that immortalized cell lines, [rom 
fetal SA progenitors as well as from other neuronal progenitors (Renfranz 
et a1 199 1; Snyder et aI 1 992), might prove llseful in sllch cell-replacement 
therapies. Animal studies are now in progress to test this idea. The pheno­
typic plasticity and multipotentiality of SA lineage cells might make them 
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useful in the treatment of other neurodegenerative diseases. For example, 
chromaffin cells and sympathetic neurons converted to a cholinergic 
phenotype by CDF/LIF have been tested for their ability to replace basal 
forebrain cholinergic neurons in an animal model of Alzheimer's disease 
( Mahanthappa et al 1 990). In this way, the study of the SA lineage may 
have broader implications for both the understanding and treatment of 
human disease. 
PERSPECTIVES 
This review has focused on the biology of one developmentally restricted 
neural crest-derived progenitor cell. Although much less is known about 
the development of other neural crest derivatives, many of the general 
features of development in the SA lineage will probably apply to other 
crest lineages, as well. These features include the following: the generation 
of restricted progenitor cells; the determination of cell fate by environ­
mental signals localized in different sites of migratory arrest; the ability 
of single environmental signals to promote one phenotype and repress 
another; the gain and loss of competence to respond to environmental 
signals during differentiation; and the ability of polypeptide growth factors 
to act sequentially as mitogens, differentiation factors, and survival factors. 
On the other hand, there are differences between the development of SA 
progenitors and that of other neural crest derivatives. Sympathoadrenal 
progenitors and sympathetic neuroblasts express differentiation genes 
(such as TH and neurofilament) while still proliferating; in other neuronal 
lineages, these genes are expressed subsequent to mitotic arrest (Anderson 
& Axcl 1 986; Rohrer & Thoenen 1 987). And, it is not yet clear whether 
the phenotypic plasticity exhibited by SA derivatives is also characteristic 
of neurons in other crest lineages. These distinctions may reflect fun­
damental differences in developmental mechanisms, or they may be super­
ficiaL Further work on other neural crest sublineages will be necessary to 
resolve these issues. 
The SA lineagc has provided a well-characterized system for molecular 
studies of neural crest development; however, there have been recent 
spectacular advanccs in other aspects of neural crest molecular biology. 
Although beyond the scope of the present article, these deserve mention. 
The identification of the proto-oncogene p 140trk as a tyrosine kinase­
containing NGF receptor has stimulated studies of signal transduction in 
PC 12 cells (Kaplan et al 1 99 1  b; Kremer et al 1 99 1 ;  Sheng & Greenberg 
1 990; Vetter et al 1 99 1 )  and has revealed mechanistic analogies with 
invertebrate systems (for reviews, see Rubin 1 99 1 ;  Sternberg & Horvitz 
1 99 1 ). The elucidation of the molecular bases of mouse mutations affecting 
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melanocyte development has focused new attention on the role of poly­
peptide growth factors and their receptors in neural crest development (for 
reviews, see Bowen-Pope et al 1 991; Marusich & Weston 1991). And, a 
functional role for homeobox genes in the patterning of the cranial neural 
crest has been established by targeted mutagenesis of some Hox genes in 
mice (for review, see Hunt & Krumlauf 1 991). Over the next decade, these 
diverse approaches should converge with cellular studies to advance our 
understanding of many aspects of neural crest development at the molec­
ular level. 
SUMMARY 
Over the past five years, new insights have been gained into the biology of 
the SA lineage. These advances have been powered by the development of 
immunologic methods to isolate embryonic SA progenitors from fetal 
adrenal glands and sympathetic ganglia. Analysis of these embryonic pro­
genitors has confirmed many of the ideas derived [rom earlier studies of 
postnatal cells, but has necessitated several revisions in our thinking, as 
well. First, embryonic SA progenitors appear to be distinct from mature 
SIF cells, a cell type initially postulated to be the central intermediate in 
the SA lineage. Second, FGF, not NGF, appears to be an important early 
influence on neuronal fate; NGF responsiveness appears relatively late in 
differentiation. Third, the development of both sympathetic neurons and 
adrenal chromaffin cells is not a one-step process, but rather involves a 
series of events, in which the cells change their responsiveness to growth 
factors and glucocorticoids. Fourth, emerging circumstantial evidence sug­
gests that SA progenitors may have additional developmental potentials. 
Finally, new insights have been gained into the molecular mechanisms that 
underlie both the differentiation of SA progenitors and their determination 
from earlier multipotent neural crest cells. These advances have made the 
SA progenitor a well-defined system for studying the molecular control of 
cell fate in a vertebrate neurogenic precursor cell. 
The analysis of the SA lineage at the cell biological level has raised 
several interesting molecular questions for future investigation. In the 
neuronal branch of the SA lineage, how is the acquisition of NG F-respon­
siveness and NGF-dependence controlled, and what is the relationship of 
these events to the expression of p l 40trk and p75? In the chromaffin branch 
of the pathway, which molecules control the timing ofPNMT expression? 
In the uncommitted SA progenitor, what is the molecular basis of the 
antagonism between the competing neuronal and chromaffin pathways of 
differentiation, and how does commitment to neuronal differentiation 
occur? Can SA progenitors differentiate to enteric neurons in vitro, and 
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which differentiation and survival factors control this phenotype, as well 
as the other classical neurotransmitter and neuropeptide phenotypes ex­
pressed by SA derivatives? What are the roles of MASHI and other 
regulatory genes in controlling early stages in neural crest cell deter­
mination, and how is the expression of these molecules in turn controlled? 
How much of the genetic regulatory network controlling neuronal differ­
entiation in Drosophila has been conserved in vertebrates? These questions, 
and the further puzzles that their answers will inevitably create, promise 
fruitful territory for future investigations as the molecular biology of 
vertebrate neurogenesis comes of age. 
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